Skip to main content
Back
Watch Compare

Traws Pharma, Inc.

Data quality: 100%
TRAW
NASDAQ Manufacturing Chemicals
$1.48
▼ $0.02 (-1.33%)
Mkt Cap: 11.93 M
Price
$1.49
Mkt Cap
11.93 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue declined -0.55% annually over 5 years
Negative free cash flow of -19.47 M
Capital efficient — spends only 0.00% of revenue on capex

Growth

Revenue Growth (5Y)
-0.55%
Below sector avg (1.82%)
Revenue (1Y)0.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-207.84%
Below sector avg (-54.01%)
ROIC-194.45%
Net Margin-467.64%
Op. Margin-554.64%

Safety

Debt / Equity
N/A
Current Ratio1.22
Interest CoverageN/A

Valuation

PE (TTM|NTM)
-0.90 | -0.34
Above sector avg (-1.49)
P/B Ratio2.62
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -0.9 -1.5
P/B 2.6 1.6
ROE % -207.8 -54.0
Net Margin % -467.6 -41.5
Rev Growth 5Y % -0.6 1.8
D/E — 0.3

Analyst Price Target

2 analysts
Buy
Current
$1.48
+389.9%
Target
$7.25
$6.50
$7.25
$8.00
Forecast
Forward P/E -0.34
Forward EPS -$4.32
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2026 -$4.32
-$4.32 – -$4.32
 0.0 1

Earnings Surprises

Last 1 quarter
Quarter Est. EPS Actual EPS Surprise
Q32025 N/A -$0.34 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0.00% Revenue Growth (3Y) 0.00%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -0.55% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.85 M Net Income (TTM) -13.31 M
ROE -207.84% ROA -94.84%
Gross Margin N/A Operating Margin -554.64%
Net Margin -467.64% Free Cash Flow (TTM) -19.47 M
ROIC -194.45% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.22
Interest Coverage N/A Asset Turnover 0.20
Working Capital 1.74 M Tangible Book Value 1.97 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.90 Forward P/E -0.34
P/B Ratio 2.62 P/S Ratio 4.19
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -163.22%
Market Cap 11.93 M Enterprise Value 11.93 M
Per Share
EPS (Diluted TTM) 97.19 Revenue / Share 0.36
FCF / Share -2.44 OCF / Share -2.44
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.00% FCF Conversion 146.27%
SBC-Adj. FCF -20.21 M Growth Momentum 0.55

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2021 FY2022 FY2019
Revenue 226,000.0 226,000.0 226,000.0 226,000.0 2.18 M
Net Income -166.52 M -18.95 M -16.16 M -18.96 M -21.50 M
EPS (Diluted) -35.21 -0.90 -0.96 -0.91 —
Gross Profit — — — — —
Operating Income -142.37 M -20.30 M -16.50 M -19.63 M -21.70 M
EBITDA — — — — —
R&D Expenses — 11.43 M 7.30 M 11.41 M 15.54 M
SG&A Expenses — — — — —
D&A 12,000.0 16,000.0 14,000.0 14,000.0 14,000.0
Interest Expense — — — — —
Income Tax — — 4,000.0 — 10,000.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2021 FY2022 FY2019
Total Assets 24.96 M 22.68 M 55.48 M 39.37 M 23.67 M
Total Liabilities 56.59 M 12.01 M 9.36 M 11.06 M 12.10 M
Shareholders' Equity -31.63 M 10.67 M 46.12 M 28.31 M 11.57 M
Total Debt — — — — —
Cash & Equivalents — 20.56 M — 38.52 M —
Current Assets 24.95 M 22.66 M 55.43 M 39.35 M 23.47 M
Current Liabilities 11.53 M 9.22 M 6.12 M 8.05 M 8.29 M